The BRAF mutation has been detected in 45% of papillary thyroid carcinoma (PTC) and in 24% of atypical subtype, whereas the mutation has not been detected in follicular and medullary thyroid carcinoma (FTC and MTC, respectively) [58]. This evidence concerns the gene BRAF and medullary thyroid gland carcinoma.